A citation-based method for searching scientific literature

N Lynn Henry, Philippe L Bedard, Angela DeMichele. Am Soc Clin Oncol Educ Book 2017
Times Cited: 4







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant,[...]. J Clin Oncol 2006
25

Limitations of Personalized Medicine and Gene Assays for Breast Cancer.
David Tiberi, Laura Masucci, Daniel Shedid, Isabelle Roy, Toni Vu, Erica Patocskai, André Robidoux, Philip Wong. Cureus 2017
6
25



West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
Oleg Gluz, Ulrike A Nitz, Matthias Christgen, Ronald E Kates, Steven Shak, Michael Clemens, Stefan Kraemer, Bahriye Aktas, Sherko Kuemmel, Toralf Reimer,[...]. J Clin Oncol 2016
138
25



Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
Marc Buyse, Sherene Loi, Laura van't Veer, Giuseppe Viale, Mauro Delorenzi, Annuska M Glas, Mahasti Saghatchian d'Assignies, Jonas Bergh, Rosette Lidereau, Paul Ellis,[...]. J Natl Cancer Inst 2006
777
25

The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients.
Salomon M Stemmer, Shmuel H Klang, Noa Ben-Baruch, David B Geffen, Mariana Steiner, Lior Soussan-Gutman, Shahar Merling, Christer Svedman, Shulamith Rizel, Nicky Lieberman. Breast Cancer Res Treat 2013
32
25

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age.
S Mook, M K Schmidt, B Weigelt, B Kreike, I Eekhout, M J van de Vijver, A M Glas, A Floore, E J T Rutgers, L J van 't Veer. Ann Oncol 2010
100
25


Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
25


Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey.
Vahit Ozmen, Ajlan Atasoy, Erhan Gokmen, Mustafa Ozdogan, Nilufer Guler, Cihan Uras, Engin Ok, Orhan Demircan, Abdurrahman Isikdogan, Pinar Saip. Cureus 2016
17
25

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.
Lawrence J Solin, Robert Gray, Lori J Goldstein, Abram Recht, Frederick L Baehner, Steven Shak, Sunil Badve, Edith A Perez, Lawrence N Shulman, Silvana Martino,[...]. Breast Cancer Res Treat 2012
47
25

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
25

GENE EXPRESSION PROFILING AND EXPANDED IMMUNOHISTOCHEMISTRY TESTS TO GUIDE SELECTION OF CHEMOTHERAPY REGIMENS IN BREAST CANCER MANAGEMENT: A SYSTEMATIC REVIEW.
Alison Scope, Munira Essat, Abdullah Pandor, Rachid Rafia, Sue E Ward, Lynda Wyld, Simon Cross, Helen Buckley Woods. Int J Technol Assess Health Care 2017
7
25

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
Fatima Cardoso, Laura J van't Veer, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean-Yves Pierga, Etienne Brain, Sylvain Causeret, Mauro DeLorenzi,[...]. N Engl J Med 2016
749
25

Breast cancer intrinsic subtype classification, clinical use and future trends.
Xiaofeng Dai, Ting Li, Zhonghu Bai, Yankun Yang, Xiuxia Liu, Jinling Zhan, Bozhi Shi. Am J Cancer Res 2015
371
25

Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer.
Valesca P Retèl, Manuela A Joore, Michael Knauer, Sabine C Linn, Michael Hauptmann, Wim H van Harten. Eur J Cancer 2010
68
25

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, E Rutgers, S Zackrisson, F Cardoso. Ann Oncol 2015
821
25



Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
Lyndsay N Harris, Nofisat Ismaila, Lisa M McShane, Fabrice Andre, Deborah E Collyar, Ana M Gonzalez-Angulo, Elizabeth H Hammond, Nicole M Kuderer, Minetta C Liu, Robert G Mennel,[...]. J Clin Oncol 2016
447
25

Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey.
Vahit Özmen, Ajlan Atasoy, Erhan Gökmen, Mustafa Özdoğan, Nilufer Güler, Cihan Uras, Engin Ok, Orhan Demircan, Abdurrahman Işıkkdoğan, Neslihan Cabioğlu,[...]. J Breast Health 2016
5
25

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
25

Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, Marc J van de Vijver, Yudong D He, Augustinus A M Hart, Mao Mao, Hans L Peterse, Karin van der Kooy, Matthew J Marton, Anke T Witteveen,[...]. Nature 2002
25

Prognostic/predictive factors in breast cancer.
Shahla Masood. Clin Lab Med 2005
27
25

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer.
Michael Knauer, Stella Mook, Emiel J T Rutgers, Richard A Bender, Michael Hauptmann, Marc J van de Vijver, Rutger H T Koornstra, Jolien M Bueno-de-Mesquita, Sabine C Linn, Laura J van 't Veer. Breast Cancer Res Treat 2010
157
25

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer.
Xiao-Jun Ma, Ranelle Salunga, Sonika Dahiya, Wilson Wang, Erin Carney, Virginie Durbecq, Adrian Harris, Paul Goss, Christos Sotiriou, Mark Erlander,[...]. Clin Cancer Res 2008
200
25

Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.
Mitch Dowsett, Jack Cuzick, Christopher Wale, John Forbes, Elizabeth A Mallon, Janine Salter, Emma Quinn, Anita Dunbier, Michael Baum, Aman Buzdar,[...]. J Clin Oncol 2010
470
25

A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
Martin Filipits, Margaretha Rudas, Raimund Jakesz, Peter Dubsky, Florian Fitzal, Christian F Singer, Otto Dietze, Richard Greil, Andrea Jelen, Paul Sevelda,[...]. Clin Cancer Res 2011
372
25

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
A S Coates, E P Winer, A Goldhirsch, R D Gelber, M Gnant, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2015
927
25

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Daniel F Hayes, Charles E Geyer, Elizabeth C Dees, Edith A Perez, John A Olson,[...]. N Engl J Med 2015
715
25

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.
Maurice P H M Jansen, Anieta M Sieuwerts, Maxime P Look, Kirsten Ritstier, Marion E Meijer-van Gelder, Iris L van Staveren, Jan G M Klijn, John A Foekens, Els M J J Berns. J Clin Oncol 2007
95
25

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Armando E Giuliano, James L Connolly, Stephen B Edge, Elizabeth A Mittendorf, Hope S Rugo, Lawrence J Solin, Donald L Weaver, David J Winchester, Gabriel N Hortobagyi. CA Cancer J Clin 2017
305
25

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
25

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
Kathy S Albain, William E Barlow, Steven Shak, Gabriel N Hortobagyi, Robert B Livingston, I-Tien Yeh, Peter Ravdin, Roberto Bugarini, Frederick L Baehner, Nancy E Davidson,[...]. Lancet Oncol 2010
897
25

Gene expression profiling in breast cancer.
Kiran Turaga, Geza Acs, Christine Laronga. Cancer Control 2010
20
25

A gene-expression signature as a predictor of survival in breast cancer.
Marc J van de Vijver, Yudong D He, Laura J van't Veer, Hongyue Dai, Augustinus A M Hart, Dorien W Voskuil, George J Schreiber, Johannes L Peterse, Chris Roberts, Matthew J Marton,[...]. N Engl J Med 2002
25

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
M J Brady, D F Cella, F Mo, A E Bonomi, D S Tulsky, S R Lloyd, S Deasy, M Cobleigh, G Shiomoto. J Clin Oncol 1997
25

An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions.
Muin J Khoury, Quanhe Yang, Marta Gwinn, Julian Little, W Dana Flanders. Genet Med 2004
71
25

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
Tanya Keenan, Beverly Moy, Edmund A Mroz, Kenneth Ross, Andrzej Niemierko, James W Rocco, Steven Isakoff, Leif W Ellisen, Aditya Bardia. J Clin Oncol 2015
110
25

Biospecimen repositories: are blood donors willing to participate?
Erik A Scott, Karen S Schlumpf, Sunitha M Mathew, Alan E Mast, Michael P Busch, Jerome L Gottschall. Transfusion 2010
24
25

Mistrust of health care organizations is associated with underutilization of health services.
Thomas A LaVeist, Lydia A Isaac, Karen Patricia Williams. Health Serv Res 2009
191
25

Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.
Jean G Ford, Mollie W Howerton, Gabriel Y Lai, Tiffany L Gary, Shari Bolen, M Chris Gibbons, Jon Tilburt, Charles Baffi, Teerath Peter Tanpitukpongse, Renee F Wilson,[...]. Cancer 2008
549
25

Functional impairment of activated protein C in breast cancer - relationship to survival outcomes.
Mario Roselli, Patrizia Ferroni, Silvia Riondino, Sabrina Mariotti, Ilaria Portarena, Jhessica Alessandroni, Cristiano Ialongo, Renato Massoud, Leopoldo Costarelli, Francesco Cavaliere,[...]. Am J Cancer Res 2016
1
100

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
25

Barriers and Strategies to Participation in Tissue Research Among African-American Men.
Bettina F Drake, Danielle Boyd, Kimberly Carter, Sarah Gehlert, Vetta Sanders Thompson. J Cancer Educ 2017
10
25

Yes, minority and underserved populations will participate in biospecimen collection.
Edward E Partridge. Cancer Epidemiol Biomarkers Prev 2014
9
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.